Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Stanford Health Care

Dermatomyositis

What is Dermatomyositis?

Dermatomyositis is a condition in which the muscles become inflamed and weak. This condition is part of a group of disorders called inflammatory myopathies.

Dermatomyositis affects more women than men. It usually occurs between the ages of 50 and 70.

How Is Dermatomyositis Diagnosed?

Dermatomyositis often responds well to treatment, but you must get an accurate diagnosis first. Because the symptoms of dermatomyositis can resemble those of other conditions, you should seek out a neuromuscular doctor with many years of experience differentiating between different diseases that mimic dermatomyositis.

Learn more about dermatomyositis diagnosis at Stanford.

How Is Dermatomyositis Treated?

Treatment may include a number of approaches, from medications and physical therapy to immunosuppressant therapies.

Learn more about dermatomyositis treatment at Stanford.

Clinical Trials for Dermatomyositis

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Open Trials